US Broker Ratings

TruBridge, Inc. (TBRG) Stock Analysis: Healthcare Innovator with a Compelling Forward P/E of 9.84

TruBridge, Inc. (NASDAQ: TBRG) stands as a robust player in the healthcare sector, specifically within the Health Information Services industry. Headquartered in Mobile, Alabama, the company is a key provider..

Pacific Biosciences of California (PACB) Stock Analysis: Navigating the Healthcare Innovator’s Path Amidst Market Challenges

Pacific Biosciences of California, Inc. (NASDAQ: PACB), a prominent player in the healthcare sector, continues to capture investor attention with its innovative sequencing solutions despite facing significant market challenges. As..

Nano-X Imaging Ltd (NNOX) Stock Analysis: Exploring a 79% Upside in the Medical Device Sector

Nano-X Imaging Ltd (NNOX), an innovative player in the healthcare sector, particularly in the medical devices industry, is garnering attention from investors with its ambitious mission to revolutionize medical imaging...

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: Unpacking the 422% Potential Upside with Strong Analyst Support

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT), a promising player in the biotechnology sector, is drawing attention with its significant potential upside and a robust pipeline of innovative therapeutics. Headquartered in..

Candel Therapeutics (CADL) Stock Analysis: Exploring a 303% Potential Upside in Cancer Immunotherapy

Candel Therapeutics, Inc. (NASDAQ: CADL) is making waves in the biotechnology sector with its promising pipeline of cancer immunotherapies. As a clinical-stage biopharmaceutical company, Candel is focused on developing innovative..

XOMA Royalty Corporation (XOMA) Stock Analysis: Biotech’s Hidden Gem with 118.85% Potential Upside

XOMA Royalty Corporation (XOMA), a key player in the biotechnology sector, is attracting significant attention from investors due to its unique business model and substantial growth potential. With a market..

Benitec Biopharma Inc. (BNTC) Stock Analysis: Exploring a Potential 98% Upside in the Biotech Space

For investors with an eye on high-potential opportunities in the healthcare sector, Benitec Biopharma Inc. (NASDAQ: BNTC) presents an intriguing prospect. As a clinical-stage biotechnology company, Benitec is pioneering advancements..

Anbio Biotechnology (NNNN) Investor Outlook: Navigating Revenue Declines and Market Volatility

Anbio Biotechnology (NNNN), a Germany-based company specializing in in vitro diagnostics (IVD), has captured the attention of the healthcare sector with its rapid growth and broad international reach. Despite its..

Zhengye Biotechnology Holding L (ZYBT) Stock Analysis: Navigating a Challenging Landscape in the Veterinary Vaccine Market

Zhengye Biotechnology Holding Limited (ZYBT), operating in the specialized sector of veterinary vaccines within the healthcare industry, presents a complex picture for investors as the company navigates through a challenging..

TotalEnergies SE (TTE) Stock Analysis: Exploring a 7.43% Potential Upside in the Energy Sector

TotalEnergies SE (TTE), a prominent player in the energy sector, has been garnering attention from investors, not least because of its robust position within the integrated oil and gas industry...

Olema Pharmaceuticals, Inc. (OLMA) Stock Analysis: A Biotech with 29.8% Upside Potential

Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) is making waves in the biotechnology sector, and for good reason. As a clinical-stage biopharmaceutical company specializing in innovative therapies for women’s cancers, Olema is..

Mereo BioPharma Group plc (MREO): Analyst Ratings Signal a Stunning 287% Potential Upside

Mereo BioPharma Group plc (NASDAQ: MREO), a London-based biopharmaceutical company, has captured the attention of investors with its robust pipeline of therapeutic candidates and a remarkable potential upside. With a..

Evolent Health, Inc (EVH) Investor Outlook: Exploring a Potential 158% Upside

Evolent Health, Inc. (NASDAQ: EVH) is a prominent player in the healthcare sector, specifically within the health information services industry. Headquartered in Arlington, Virginia, Evolent Health provides a suite of..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Exploring a 47% Potential Upside

For investors seeking opportunities in the healthcare sector, U.S. Physical Therapy, Inc. (NYSE: USPH) presents a compelling proposition. With a market capitalization of $1.09 billion, this Houston-based company operates in..

Wave Life Sciences Ltd. (WVE) Stock Analysis: Exploring a 165% Potential Upside in Biotech Innovation

Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage biotechnology firm based in Singapore, has been garnering considerable attention from investors due to its innovative approach to RNA medicines and a..

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: Navigating Growth with a 16.7% Potential Upside

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH), a key player in the U.S. medical care facilities industry, is capturing investor attention with its robust growth prospects and significant potential upside. With..

Teladoc Health, Inc. (TDOC) Investor Outlook: Exploring a Potential 27.68% Upside

Teladoc Health, Inc. (NASDAQ: TDOC) stands at a pivotal point in the healthcare sector’s evolution, offering a unique blend of virtual healthcare services designed to meet the growing demand for..

Clover Health Investments (CLOV): Analyzing Its 34.72% Potential Upside and Revenue Surge

Clover Health Investments, Corp (NASDAQ: CLOV), a key player in the healthcare plans sector, presents a captivating prospect for investors with its compelling 34.72% potential upside. As a company that..

Novavax, Inc. (NVAX) Stock Analysis: Exploring a Potential 91% Upside in the Biotech Arena

Novavax, Inc. (NVAX), a prominent player in the biotechnology sector, is making headlines with a potential upside of 91.05%, according to analyst consensus. Known for its innovative approach in vaccine..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Exploring a 30% Potential Upside in the Healthcare Sector

Pacira BioSciences, Inc. (NASDAQ: PCRX) stands out in the healthcare sector with a specialized focus on non-opioid pain management solutions. With its current market cap at $1.04 billion, this U.S.-based..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds